Miraculins, Inc.

Miraculins, Inc.

Sector: Commercial Physical And Biological Research Region: Canada

: | TSX Venture Exchange: MOM | OTC Markets: MCUIF

Similar to: Advanced Cell Technology, Inc., Medivir AB, Exelixis, Inc.

Miraculins, Inc. is a medical diagnostic company, which is focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs. Its PreVu test is a revolutionary coronary artery disease risk assessment technology that measures cholesterol levels in a patient's skin non-invasively, painlessly and without the need for fasting. The company's additional programs include ELISA kit for the detection of PSP94; and a suite of biomarkers to aid in the early detection of the devastating disease of pregnancy known as preeclampsia. Miraculins was founded on June 27, 1998 and is headquartered in Winnipeg, Canada.

News & Analysis

You may also be interested in: